206 related articles for article (PubMed ID: 10535925)
1. Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1.
Kim YH; Choi CY; Kim Y
Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12350-5. PubMed ID: 10535925
[TBL] [Abstract][Full Text] [Related]
2. Control of nuclear HIPK2 localization and function by a SUMO interaction motif.
de la Vega L; Fröbius K; Moreno R; Calzado MA; Geng H; Schmitz ML
Biochim Biophys Acta; 2011 Feb; 1813(2):283-97. PubMed ID: 21145359
[TBL] [Abstract][Full Text] [Related]
3. Regulation of homeodomain-interacting protein kinase 2 (HIPK2) effector function through dynamic small ubiquitin-related modifier-1 (SUMO-1) modification.
Hofmann TG; Jaffray E; Stollberg N; Hay RT; Will H
J Biol Chem; 2005 Aug; 280(32):29224-32. PubMed ID: 15958389
[TBL] [Abstract][Full Text] [Related]
4. Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability.
Gresko E; Möller A; Roscic A; Schmitz ML
Biochem Biophys Res Commun; 2005 Apr; 329(4):1293-9. PubMed ID: 15766567
[TBL] [Abstract][Full Text] [Related]
5. Desumoylation of homeodomain-interacting protein kinase 2 (HIPK2) through the cytoplasmic-nuclear shuttling of the SUMO-specific protease SENP1.
Kim YH; Sung KS; Lee SJ; Kim YO; Choi CY; Kim Y
FEBS Lett; 2005 Nov; 579(27):6272-8. PubMed ID: 16253240
[TBL] [Abstract][Full Text] [Related]
6. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
[TBL] [Abstract][Full Text] [Related]
7. Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification.
Kurtzman AL; Schechter N
Proc Natl Acad Sci U S A; 2001 May; 98(10):5602-7. PubMed ID: 11331779
[TBL] [Abstract][Full Text] [Related]
8. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-dependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2.
Roscic A; Möller A; Calzado MA; Renner F; Wimmer VC; Gresko E; Lüdi KS; Schmitz ML
Mol Cell; 2006 Oct; 24(1):77-89. PubMed ID: 17018294
[TBL] [Abstract][Full Text] [Related]
10. The DNA topoisomerase I binding protein topors as a novel cellular target for SUMO-1 modification: characterization of domains necessary for subcellular localization and sumolation.
Weger S; Hammer E; Engstler M
Exp Cell Res; 2003 Oct; 290(1):13-27. PubMed ID: 14516784
[TBL] [Abstract][Full Text] [Related]
11. SUMO, ubiquitin's mysterious cousin.
Müller S; Hoege C; Pyrowolakis G; Jentsch S
Nat Rev Mol Cell Biol; 2001 Mar; 2(3):202-10. PubMed ID: 11265250
[TBL] [Abstract][Full Text] [Related]
12. Ubch9 conjugates SUMO but not ubiquitin.
Desterro JM; Thomson J; Hay RT
FEBS Lett; 1997 Nov; 417(3):297-300. PubMed ID: 9409737
[TBL] [Abstract][Full Text] [Related]
13. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals.
Isono K; Nemoto K; Li Y; Takada Y; Suzuki R; Katsuki M; Nakagawara A; Koseki H
Mol Cell Biol; 2006 Apr; 26(7):2758-71. PubMed ID: 16537918
[TBL] [Abstract][Full Text] [Related]
14. Human homeodomain-interacting protein kinase-2 (HIPK2) is a member of the DYRK family of protein kinases and maps to chromosome 7q32-q34.
Hofmann TG; Mincheva A; Lichter P; Dröge W; Schmitz ML
Biochimie; 2000 Dec; 82(12):1123-7. PubMed ID: 11120354
[TBL] [Abstract][Full Text] [Related]
15. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors.
Kim YH; Choi CY; Lee SJ; Conti MA; Kim Y
J Biol Chem; 1998 Oct; 273(40):25875-9. PubMed ID: 9748262
[TBL] [Abstract][Full Text] [Related]
16. Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2.
Saitoh H; Sparrow DB; Shiomi T; Pu RT; Nishimoto T; Mohun TJ; Dasso M
Curr Biol; 1998 Jan; 8(2):121-4. PubMed ID: 9427648
[TBL] [Abstract][Full Text] [Related]
17. Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.
Tatham MH; Jaffray E; Vaughan OA; Desterro JM; Botting CH; Naismith JH; Hay RT
J Biol Chem; 2001 Sep; 276(38):35368-74. PubMed ID: 11451954
[TBL] [Abstract][Full Text] [Related]
18. Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.
Giraud MF; Desterro JM; Naismith JH
Acta Crystallogr D Biol Crystallogr; 1998 Sep; 54(Pt 5):891-8. PubMed ID: 9757105
[TBL] [Abstract][Full Text] [Related]
19. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2.
Okuma T; Honda R; Ichikawa G; Tsumagari N; Yasuda H
Biochem Biophys Res Commun; 1999 Jan; 254(3):693-8. PubMed ID: 9920803
[TBL] [Abstract][Full Text] [Related]
20. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
Sampson DA; Wang M; Matunis MJ
J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
